InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Praill Anthony Scott, Chief Financial Officer. Insider active across 1 company, notably Kintara Therapeutics, Inc.. Cumulatively, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €34k. History available since 8 December 2021. The latest transaction was filed on 8 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
28,700 shares@ US$0.67750.0% of flowCommon StockSEC:0000899243-21-047520:0
Ideal exit: 4 Sept 2022 (T+270)
28,700 shares@ US$0.677100.0% of flowCommon StockSEC:0000899243-21-047520
Ideal exit: 4 Sept 2022 (T+270)
2 of 2 declarations
About Praill Anthony Scott
Anthony Scott Praill is the Chief Financial Officer at Kintara Therapeutics, Inc. In this role, he is responsible for the company's financial management, including financial planning and reporting. Praill plays a key role in Kintara's financial strategy, contributing to its growth and profitability.
